share_log

HC Wainwright & Co. Reiterates Buy on Aridis Pharmaceuticals, Maintains $2 Price Target

HC Wainwright & Co. Reiterates Buy on Aridis Pharmaceuticals, Maintains $2 Price Target

HC Wainwright & Co.重申買入Aridis Pharmicals,維持2美元的目標股價
Benzinga ·  2023/11/06 07:05

HC Wainwright & Co. analyst Vernon Bernardino reiterates Aridis Pharmaceuticals (OTC:ARDS) with a Buy and maintains $2 price target.

HC Wainwright & Co. 分析師弗農·貝納迪諾重申Aridis Pharmicals(場外交易代碼:ARDS)買入並維持2美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論